Get started
Ocumension TherapeuticsOcumension TherapeuticsOcumension Therapeutics

Ocumension Therapeutics

No trades
See on Supercharts
Overview
Financials News Discussions Forecast Seasonals

5DG chart


Full chart

5DG upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪937.46 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.04 EUR
Net income (FY)
‪−36.16 M‬ EUR
Revenue (FY)
‪56.24 M‬ EUR
Shares float
‪344.25 M‬
Beta (1Y)
1.30

Employees


Employees (FY)
489
Change (1Y)
+45 +10.14%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Ocumension Therapeutics


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ye Liu
Website
ocumension.com
Headquarters
Suzhou
Founded
2018
ISIN
KYG674111011
FIGI
BBG00W1MFTW4
Ocumension Therapeutics engages in the identification, development, and commercialization of ophthalmic therapies. The company was founded in 2017 and is headquartered in Suzhou, China.

Check out other big names from the same industry as 5DG.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

5DG news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Ocumension Therapeutics stocks are traded under the ticker 5DG.
We've gathered analysts' opinions on Ocumension Therapeutics future price: according to them, 5DG price has a max estimate of 1.35 EUR and a min estimate of 1.12 EUR. Watch 5DG chart and read a more detailed Ocumension Therapeutics stock forecast: see what analysts think of Ocumension Therapeutics and suggest that you do with its stocks.
5DG reached its all-time high on Jul 16, 2020 with the price of 3.85 EUR, and its all-time low was 0.001 EUR and was reached on Apr 13, 2016. View more price dynamics on 5DG chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Ocumension Therapeutics financials in yearly and quarterly reports right on TradingView.
Ocumension Therapeutics is going to release the next earnings report on Mar 20, 2026. Keep track of upcoming events with our Earnings Calendar.
5DG earnings for the last half-year are −0.02 EUR per share, whereas the estimation was −0.01 EUR, resulting in a −41.67% surprise. The estimated earnings for the next half-year are 0.00 EUR per share. See more details about Ocumension Therapeutics earnings.
Ocumension Therapeutics revenue for the last half-year amounts to ‪34.83 M‬ EUR, despite the estimated figure of ‪37.63 M‬ EUR. In the next half-year revenue is expected to reach ‪60.89 M‬ EUR.
5DG net income for the last half-year is ‪−15.37 M‬ EUR, while the previous report showed ‪−15.77 M‬ EUR of net income which accounts for 2.55% change. Track more Ocumension Therapeutics financial stats to get the full picture.
No, 5DG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 9, 2025, the company has 489 employees. See our rating of the largest employees — is Ocumension Therapeutics on this list?
Like other stocks, 5DG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ocumension Therapeutics stock right from TradingView charts — choose your broker and connect to your account.